Biological Safety Testing Products and Services Market Size will Grow from 2019 to 2029 at an estimated CAGR of 12.29% | Straits Research

Biological Safety Testing Products and Services Market

The biological safety testing products and services market size was valued at USD 2.93 billion in 2019 and is anticipated to grow with a CAGR of 12.29%.

Biological safety testing is conducted to ensure that biopharmaceutical products such as therapeutics, drugs, blood, and blood-derived products, vaccines, stem cells, and tissue banks are contamination-free. The biological safety testing products include a set of assays using preclinical and clinical vector products. These products must undergo preclinical testing reviewed by the Food and Drug Administration (FDA) to ensure optimum safety.
The biological safety products and services market’s most prominent driver is the rising production of new generation biologics by major pharmaceutical and biotechnology companies. Additionally, the manufacturers are channelizing efforts to improve their productivity to sustain in the raging competition. Thus, they are implementing good manufacturing practices (GMP) and employing biological testing at various levels of the production cycle to ensure the utmost safety and efficiency of the products.

The rising number of drug approvals by the USFDA accelerates the market growth. The Center for Drug Evaluation and Research (CDER), in 2018, approved more than 50 novel drugs and biologics. In 2019, the FDA approved ‘Balversa’ (Erdafitinib) tablet for the treatment of metastatic bladder cancer. The FDA also approved the ‘Therascreen FGFR RGQ-PCR Kit,’ used for therapeutic indication. Apart from this, the growing focus of pharmaceutical manufacturing companies to avoid transmission and maximize drug safety drives the adoption of biological safety testing instruments.

Globally, the incidences of biological hazards are increasing at a concerning rate, which is further surging the need for biological safety testing kits. The governments have imposed stringent regulations on the pharmaceutical sector to control the incidences of microbial contamination.  The FDA has also announced several regulatory standards and guidelines, which include establishing a strong quality management system, obtaining appropriate quality raw materials, establishing robust operating procedures, and maintaining reliable testing laboratory. Similarly, bio-safety levels have been established to address the issue of contamination, which ranges from level one to four with a high focus on the control of specific microbe containment.

The COVID-19 outbreak is rising the need for vaccines across the globe. As of July 2019, the Association of British Pharmaceutical Industry (ABPI) announced that there are more than 260 vaccines in the pipeline for the treatment and prevention of various infectious diseases. Several research institutes are providing affordable third part services for maintaining the quality and efficiency of drug manufacturing. The test kits and reagents segment is expected to hold the largest market share during the forecast period. Reagents are extensively used in biological safety and testing, R&D activities, and clinical laboratories. The various types of reagents include freezing & dissociation reagents, and miscellaneous reagents. 

North America’s biological safety testing products and services market is backed by the presence of the U.S., which is bolstered by the rapidly expanding pharmaceutical sector. Additionally, favorable government regulations, robust healthcare infrastructure, increasing R&D spending, and the development of innovative technologies drive regional market growth. The first automated biological safety procedure was conducted in the U.S., which offered high accuracy with minimum human interference. The country is also witnessing rapid growth in the number of biosafety laboratories, further driving the market growth.

Obtain Brochure For Latest Technology Advancements @ 
https://straitsresearch.com/report/biological-safety-testing-products-and-services-market/request-sample

The Major Prominent Players Covered in this Report:
Charles River Laboratories
Lonza Group
MilliporeSigma
Merck
Sartorius Stedim
BioOutsource Limited

By Product, Test kits and reagents, Instruments, Services
By Application, Blood and blood-based products, Vaccines and therapeutics, Stem cells
By Test, Endotoxin test, Sterility test, Adventitious agent and virus testing

NOTE: Our analysts monitoring the situation across the globe explains that the market will generate remunerative prospects for producers post the COVID-19 crisis. The report aims to provide an additional illustration of the latest scenario, economic slowdown, and COVID-19 impact on the overall industry.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth rate of Steerable Medical Devices in these regions, from 2019 to 2029, covering:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

View this report with a detailed description and TOC @ 
https://straitsresearch.com/report/biological-safety-testing-products-and-services-market/toc

Impact of COVID-19 - 
The COVID-19 has severely impacted the world, with the death toll rising at a concerning rate every day. As per the Center for Disease Control and Prevention (CDC), new laboratory tests have been introduced to identify the COVID-19 specimens, which is further accelerating market growth. The state and local public health departments are actively working to collect the specimens, which is further driving the demand for biological safety testing kits. The World Health Organization (WHO) recommended the use of new point-of-care immunodiagnostic tests in the research settings. 

The Indian Council of Medical Research (ICMR) enabled subsidized tests due to National Public Health Emergency. The market players are supplying their diagnostic test kits to the private labs to make test operations feasible. The ICMR instructed the laboratories to undertake appropriate biosafety and biosecurity precautions while collecting samples. For biological safety testing, ICMR has urged the laboratories and hospitals to create a separate disease-specific sample collection site.

Key Biological Safety Testing Products and Services Market Trends:
- The report identifies, determines, and forecasts the Global Biological Safety Testing Products and Services Market segments based on their type, sub-type, technology used, applications, end-users, and regions.
- Industry to Industry Holds Largest Share in the Biological Safety Testing Products and Services Market
- It examines the micro-markets based on their growth trends, development patterns, future prospects, and contribution to the overall market.
- Demand from Regional / geographical is Expected to Drive the Growth
- Rising Adoption of Market Segments in this Growth
- North American, Europe is Expected to Witness Higher Growth Rate over the Forecast Period
- It studies the competitive developments such as partnerships and collaborations, mergers and acquisitions (M&A), research and development (R&D) activities, product developments, and expansions in the Global Biological Safety Testing Products and Services Market.

Key Questions Answered in The Report:
What will the Biological Safety Testing Products and Services market growth rate?
What are the key factors driving the global Biological Safety Testing Products and Services market?
Who are the key manufacturers in the Biological Safety Testing Products and Services market space?
What are the market opportunities, market risk, and market overview of the Biological Safety Testing Products and Services market?
What are sales, revenue, and price analysis of top manufacturers of the Biological Safety Testing Products and Services market?
Who are the distributors, traders, and dealers of the Biological Safety Testing Products and Services market?
What are the market opportunities and threats faced by the vendors in the global Steerable Medical Devices Industry?
What are sales, revenue, and price analysis by types and applications of the Biological Safety Testing Products and Services Industry?
What are sales, revenue, and price analysis by regions of Biological Safety Testing Products and Services industry?
What are the driving factors contributing to market growth during the short, medium, and long term?

Browse Full Report @ 
https://straitsresearch.com/report/biological-safety-testing-products-and-services-market/

Even if your business is a multinational venture or a single storefront, we believe innovation is the key to progress, in both what you build and how you promote your products and brands.

Buy Full Report with Detail Analysis with COVID-19 Impact – https://straitsresearch.com/buy-now/biological-safety-testing-products-and-services-market/global/

So let's put our minds together. We'll make your vision a reality and help you grow.

For more details, please contact us -
Straits Research
Email: sales@straitsresearch.com
Address: 825 3rd Avenue, New York, NY 10022
Tel: +1 646 480 7505, +44 208 068 9665
Website: https://straitsresearch.com/

About Us:
Regardless of whether you're looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with what customers purchase. We overcome the issues of our customers by recognizing and deciphering just the target group, while simultaneously generating leads with the highest precision. We seek to collaborate with our customers to deliver a broad spectrum of results through a blend of market and business research approaches. This approach of using various research and analysis strategies enables us to determine greater insights by eliminating the research costs.

This release was published on openPR.